MENU
+Compare
FEMY
Stock ticker: NASDAQ
AS OF
Jun 11, 04:58 PM (EDT)
Price
$0.84
Change
+$0.04 (+5.00%)
Capitalization
33.56M

FEMY Femasys Forecast, Technical & Fundamental Analysis

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas... Show more

FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for FEMY with price predictions
Jun 10, 2025

FEMY's RSI Oscillator is sitting in oversold zone for 7 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FEMY advanced for three days, in of 153 cases, the price rose further within the following month. The odds of a continued upward trend are .

FEMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for FEMY turned negative on May 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for FEMY moved below the 200-day moving average on May 30, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FEMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FEMY entered a downward trend on June 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.565) is normal, around the industry mean (24.397). P/E Ratio (4.167) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (20.450) is also within normal values, averaging (42.944).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. FEMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FEMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

FEMY is expected to report earnings to fall 25.00% to -17 cents per share on August 06

Femasys FEMY Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.04
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.05
The last earnings report on May 09 showed earnings per share of -23 cents, missing the estimate of -18 cents. With 1.92M shares outstanding, the current market capitalization sits at 33.56M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
3950 Johns Creek Court
Phone
+1 770 500-3910
Employees
34
Web
https://www.femasys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JUNS0.970.07
+7.56%
Jupiter Neurosciences Inc
JAKK22.490.73
+3.35%
JAKKS Pacific
NOAH11.920.34
+2.94%
Noah Holdings Limited
KRG22.830.19
+0.84%
Kite Realty Group Trust
ALL196.40-4.37
-2.18%
Allstate Corp (The)

FEMY and Stocks

Correlation & Price change

A.I.dvisor tells us that FEMY and BLFS have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and BLFS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
-0.01%
BLFS - FEMY
29%
Poorly correlated
+0.29%
OM - FEMY
28%
Poorly correlated
-2.78%
COO - FEMY
27%
Poorly correlated
+1.00%
GH - FEMY
25%
Poorly correlated
+1.13%
OSUR - FEMY
25%
Poorly correlated
+4.55%
More